Zimmer Biomet Holdings (ZBH) Common Equity (2009 - 2026)

Zimmer Biomet Holdings has reported Common Equity for 18 years, with the latest figure at $12.6 billion in Q2 2026.

• On a quarterly basis, Common Equity rose 0.78% year-over-year to $12.6 billion in Q2 2026; TTM through Jun 2026 was $12.6 billion, a 0.78% increase from a year earlier, with the FY2025 full-year figure at $12.7 billion, up 1.84% from the prior year.
• Common Equity was $12.6 billion for Q2 2026 at Zimmer Biomet Holdings, roughly flat from $12.7 billion in the prior quarter.
• The five-year high for Common Equity was $12.8 billion in Q3 2025, with the low at $12.0 billion in Q1 2022.
• Average Common Equity over 5 years is $12.4 billion, with a median of $12.5 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Common Equity retreated 5.05% in 2022, then grew 3.83% in 2023.
• Over 5 years, Common Equity stood at $12.0 billion in 2022, then grew by 3.83% to $12.5 billion in 2023, then dropped by 0.1% to $12.5 billion in 2024, then advanced by 1.84% to $12.7 billion in 2025, then retreated by 0.58% to $12.6 billion in 2026.
• The last three Common Equity figures came in at $12.6 billion (Q2 2026), $12.7 billion (Q1 2026), and $12.7 billion (Q4 2025), per Business Quant data.